Topic
Voluntary Disclosure
186 published works
Health Law Rx
A Six-Month Window: DOJ and HHS Offer Defined Terms for Healthcare False Claims Act Self-Disclosures
By Noam Fischman, Ameer Al-Khudari
One of the hardest questions that healthcare organizations that uncover a potential False Claims Act (FCA) problem have is whether to self-disclose an issue and at what cost. On October…
Hall, Render, Killian, Heath & Lyman, P.C. Blog
A Limited Window and Lower Multiplier: DOJ and HHS Launch New FCA Self-Disclosure Pilot Program
By Hall Render
On October 22, 2026, the U.S. Department of Justice (“DOJ”) Civil Division and the U.S. Department of Health & Human Services (“HHS”) launched the Healthcare False Claims Act Self-Disclosure Pilot…
Duane Morris Health Law
Disclose, Repay, Move Forward – What the DOJ-HHS Civil Fraud Self-Disclosure Pilot Offers Healthcare Providers
By Duane Morris
By Daniel R. Walworth, Erin M. Duffy and Nicolette TaberHealthcare organizations face uncertainty in evaluating outcomes from disclosing billing or financial relationships that could give rise to False Claims Act…
Health Law Diagnosis
DOJ and HHS-OIG Coordinate Healthcare Fraud Self-Disclosures; DOJ Launches Fraud Whistleblower Rewards Program
By Danielle Tangorre, Guest Contributor
New policy offers companies single-disclosure path to seek the benefits of both DOJ’s criminal corporate enforcement policy and HHS-OIG’s Self-Disclosure Protocol; appropriate path depends on whether conduct may be criminal.…
Hall, Render, Killian, Heath & Lyman, P.C. Blog
One Disclosure, Dual Benefits: DOJ and HHS-OIG Create a New Path for Self-Reporting Health Care Fraud
By Hall Render
On October 15, 2026, the U.S. Department of Justice (“DOJ”) National Fraud Enforcement Division (“Fraud Division”) and the U.S. Department of Health and Human Services Office of the Inspector General…
Arnold & Porter: News & Perspectives
Lisa Re Unpacks DOJ and OIG Disclosure Options with Report on Medicare Compliance
Lisa Re, Arnold & Porter Life Sciences & Healthcare Regulatory partner and former Assistant Inspector General for Legal Affairs at the U.S. Department of Health and Human Services Office of…
Inside the False Claims Act
DOJ, HHS-OIG Streamline Healthcare Fraud Self-Disclosures, but Leave Civil FCA Exposure Unaddressed
By Denise Barnes, Ben Schrader
The U.S. Department of Justice (DOJ) and the Department of Health and Human Services Office of Inspector General (HHS-OIG) unveiled a coordinated voluntary self-disclosure policy that allows healthcare companies to…
Original Source
DOJ and HHS Launch Healthcare FCA Self-Disclosure Pilot Program with Fixed Repayment Multiplier
By Kristin Graham Koehler, Jaime L.M. Jones, Lisa H. Miller, Kenneth G. Coffin, Matt Bergs
On October 22, 2026, the Department of Justice (“DOJ”) Civil Division and the Department of Health and Human Services (“HHS”) announced a six-month Healthcare False Claims Act Self-Disclosure Pilot Program…
Rivkin Rounds
DOJ and HHS Coordinate Self-Disclosure Policies
By Jeff Kaiser
On October 15, Assistant Attorney General Colin M. McDonald issued a Memo announcing new coordination between the National Fraud Enforcement Division (NFED) and the U.S. Department of Health and Human…
Original Source
DOJ Fraud Division and HHS-OIG Announce Joint Self-Disclosure Policy, Directing Healthcare Companies to Bring Potential Criminal Matters to DOJ First
By Jaime L.M. Jones, Kristin Graham Koehler, Lisa H. Miller, Matt Bergs, Lauren E. McBride, Anna M. Schmitt
On October 15, 2026, the Department of Justice’s National Fraud Enforcement Division (“NFED”) and the Department of Health and Human Services Office of Inspector General (“HHS-OIG”) announced a joint policy…